These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3102280)

  • 1. Conformational responses of an arachidonate- and U46619-binding haemoprotein in relation to platelet activation.
    Krishnan LK; Jamaluddin MP
    FEBS Lett; 1987 Feb; 212(2):213-9. PubMed ID: 3102280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular mechanism for the biphasic effect of exogenous arachidonate on platelets.
    Jamaluddin MP; Krishnan LK
    FEBS Lett; 1985 Apr; 183(2):287-92. PubMed ID: 3921404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in mouse platelet aggregation.
    Torres Duarte AP; Ramwell P; Myers A
    Thromb Res; 1986 Jul; 43(1):33-9. PubMed ID: 3088759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
    Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of human platelets exposed to arachidonate upon stimulation with other agonists: possible role of Ca2+i movement.
    Chen ZM; Cerletti C; de Gaetano G; Bertelé V
    Biochem Biophys Res Commun; 1987 Dec; 149(3):1193-9. PubMed ID: 3122746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachidonate is an antagonist of platelet activation by the endoperoxide analog U46619.
    Huang EM; Detwiler TC
    Biochim Biophys Acta; 1982 Apr; 715(2):246-9. PubMed ID: 6803846
    [No Abstract]   [Full Text] [Related]  

  • 10. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal platelet response to thromboxane A2.
    Wu KK; Le Breton GC; Tai HH; Chen YC
    J Clin Invest; 1981 Jun; 67(6):1801-4. PubMed ID: 6263954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil.
    Mazurov AV; Menshikov MYu ; Leytin VL; Tkachuk VA; Repin VS
    FEBS Lett; 1984 Jul; 172(2):167-71. PubMed ID: 6086387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet aggregation by monoclonal antibody reactive with beta 2-microglobulin chain of HLA complex.
    Curry RA; Messner RP; Johnson GJ
    Science; 1984 May; 224(4648):509-11. PubMed ID: 6324346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet arachidonate metabolism and platelet function in zinc-deficient rats.
    Gordon PR; Browning JD; O'Dell BL
    J Nutr; 1983 Apr; 113(4):766-72. PubMed ID: 6403678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets.
    Vrzheshch PV; Tatarintsev AV; Yershov DE; Varfolomeyev SD
    Thromb Res; 1992 Jun; 66(5):537-47. PubMed ID: 1523610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metabolized and unmetabolized arachidonate on rat platelet shape change.
    Lampugnani MG; de Gaetano G
    Am J Physiol; 1984 Sep; 247(3 Pt 2):H440-5. PubMed ID: 6433724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation induced by a stable analogue of endoperoxides (U46619).
    Zatta A; Prosdocimi M
    Thromb Haemost; 1989 Apr; 61(2):328-9. PubMed ID: 2526389
    [No Abstract]   [Full Text] [Related]  

  • 18. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
    Turini ME; Holub BJ
    Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.